Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trialHuabin Hu, Yanhong Deng, Hui Wang et al.|The Lancet. Gastroenterology & hepatology|2021Cited by 304
China special issue on gastrointestinal tumors‐Radiological features of pathological complete response in mismatch repair deficient colorectal cancer after neoadjuvant <scp>PD</scp>‐1 blockade: A post hoc analysis of the <scp>PICC</scp> phase <scp>II</scp> trialWuteng Cao, Yanhong Deng, Huabin Hu et al.|International Journal of Cancer|2023Cited by 17